Navigation Links
Millennium Over-Delivers on 2007 Goals and Financial Guidance
Date:2/7/2008

e year ended December 31, 2006, the Company recognized a $19.5 million gain upon receipt of a termination fee as a result of the termination of the support agreement with AnorMED in October 2006, net of transaction costs of approximately $5.5 million. Transaction costs are included in selling, general and administrative expenses.

Millennium Pharmaceuticals, Inc.

Condensed Consolidated Balance Sheets

(unaudited)

December 31, December 31,

2007 2006

(in thousands)

Cash, cash equivalents and marketable

securities $891,276 $894,349

Other current assets 142,794 121,305

Property and equipment, net 147,869 153,349

Restricted cash and other assets 37,611 35,500

Goodwill and intangible assets, net 1,516,950 1,547,309

Total assets $2,736,500 $2,751,812

Current liabilities $132,475 $125,948

Current portion of long term debt - 99,571

Other long term liabilities 43,337 56,075

Capital lease obligations, net of

current portion 73,795 75,041

Long term debt, net of current portion 250,000 250,000

Stockholders' equity 2,236,893 2,145,177

Total liabilities and

stockholders' equity $2,736,500 $2,751,812


'/>"/>
SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation
2. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
3. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
4. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
5. Life Sciences Leader Joins Millennium Board of Directors
6. Millennium to Webcast Third-Quarter 2007 Financial and Operational Results
7. Millennium Reports Outstanding Third-Quarter Results Driven by VELCADE(R) (Bortezomib) for Injection Sales
8. Millennium Research Group Offers New Marketrack Service that Tracks European Dental Implant Market
9. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
10. Millennium Ships and Records the First $200,000 of Revenue Generated From the Five-Year $20,000,000 Exclusive Purchase Order
11. Millennium to Receive $40 Million Milestone Payment for Achievement of Sales Threshold for Velcade(R) (Bortezomib) for Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...,s University Belfast is to become the United King... counter malicious ,cyber-attacks, after a funding...Research Council. , Almost 7m from the EPSRC wi... - the Centre for Secure Information Technologies ...of Electronics, Communications and Information Tec...
(Date:11/20/2008)...mpact of NC,s biotechnology sector is $45.8 billio... N.C., Nov. 20 North Ca...panding biotechnology enterprise during the past 1...5 billion, according to data released today at the...orris Tolson, president and CEO of the Biotechnolo...
(Date:11/20/2008)...FF LAKE, N.J., Nov. 20 P...oday announced that the U.S. District Court for th...eneca Pharmaceuticals, motion for a temporary rest...c Pulmicort Respules(R) (budesonide inhaled soluti...t Teva, AstraZeneca agreed and that it too would h...
(Date:11/20/2008)..., N.J., Nov. 20 At a mee...WYE ), held today, a dividend of fifty cents($0.50... Stock was declared,payable on January 2, 2009 to...on December 12, 2008. , Wyeth is one of the...d,health care products companies. It is a leader...
Breaking Biology Technology:Queen's 'secures' £25m for UK's cyber-safety 2North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 2North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 3North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 4North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 5Par Pharmaceutical Halts Shipment of Budesonide Inhalation Suspension 2
... and David Batey, Ph.D. , MJ Research, I... Abstract , We present a real-time qua..., and quantitation of soy genetically modif...yphosate. The assay utilizes SYBR Green I (SGI) de... modified organism (GMO) specific sequences as wel...
...ic DNA Tissue Kit , Catalog #732-6343, ...paraffinization , 1. Place 510 mg (0.00...ed , tube. Add 300 l xylene and incubate ...erature. , 2. Centrifuge at 13,00016,000 x...card the xylene. , 3. Repeat steps 1 and 2...
... Zoller, Theresa Redila-Flores, Dan Chu, and,Asm... As the number of diseases and disorders linke...scanning single-base mutations becomes ever more v...ase-risk predictor mutations and their , ...ges, a number of methods , that are faste...
...nen*, H.-L. Malinen*, V.-P. Jaakola** and , ...hnology Laboratory, REDEC of Kajaani, University o... ** Department of Biological and Environmen...35, FIN-40351 Jyvskyl, Finland , , ... (βLG) is a major whey protein found in the m...
Other Biology Technology:Detection of Genetically Modified Soybean in Processed Foods Using Real-Time Quantitative PCR with SYBR Green I Dye on the DNA Engine Opticon 2 System 2Detection of Genetically Modified Soybean in Processed Foods Using Real-Time Quantitative PCR with SYBR Green I Dye on the DNA Engine Opticon 2 System 3Detection of Genetically Modified Soybean in Processed Foods Using Real-Time Quantitative PCR with SYBR Green I Dye on the DNA Engine Opticon 2 System 4Detection of Genetically Modified Soybean in Processed Foods Using Real-Time Quantitative PCR with SYBR Green I Dye on the DNA Engine Opticon 2 System 5Detection of Genetically Modified Soybean in Processed Foods Using Real-Time Quantitative PCR with SYBR Green I Dye on the DNA Engine Opticon 2 System 6Detection of Genetically Modified Soybean in Processed Foods Using Real-Time Quantitative PCR with SYBR Green I Dye on the DNA Engine Opticon 2 System 7Detection of Genetically Modified Soybean in Processed Foods Using Real-Time Quantitative PCR with SYBR Green I Dye on the DNA Engine Opticon 2 System 8DNA Isolation From 50 to 20 mg of Paraffin-Embedded Tissue 2Temporal Temperature Gradient Electrophoresis: A Powerful Technique to Screen Mutations 2Temporal Temperature Gradient Electrophoresis: A Powerful Technique to Screen Mutations 3Temporal Temperature Gradient Electrophoresis: A Powerful Technique to Screen Mutations 4Temporal Temperature Gradient Electrophoresis: A Powerful Technique to Screen Mutations 5Temporal Temperature Gradient Electrophoresis: A Powerful Technique to Screen Mutations 6Temporal Temperature Gradient Electrophoresis: A Powerful Technique to Screen Mutations 7Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 2Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 3Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 4Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 5Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 6Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 7Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 8Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 9Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 10Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 11Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 12
(Date:11/19/2008)...health threat to city dwellers posed by Southern C...y have been underestimated by officials. , Detai...previous California wild fires indicates that the ...o health than is generally realized, according to ... wildfires in Southern California. , The paper, ...
(Date:11/19/2008)... of marine invertebrates worms, sponges, jellyfis...t of no more than two cells: a photoreceptor cell ...spots, resemble the ,proto-eyes, suggested by Char...volution. They cannot form images but allow the an... is crucial for phototaxis the swimming towards l...
(Date:11/19/2008)...ists at St. Jude Children,s Research Hospital have... body,s enzyme workhorses called calpains. , As...tion in many cellular processes, including the mov...lls, insulin secretion, and brain cell and muscle ...sibilities is that defective or overactive calpain...
(Date:11/19/2008)... 24, 2008 -- From the collapse of star-forming clo...he combustion of gasoline in your car engine to th...ics of flight to the concentration of microscopic ...ating phenomena are forms of fluid flow. , The 6...y,s Division of Fluid Dynamics, which takes place ...
Breaking Biology News(10 mins):Where there's wildfire smoke, there's toxicity 2Uncovering secrets of life in the ocean 2New insight into the controls on a go-to enzyme 2New insight into the controls on a go-to enzyme 3The physics of star-forming clouds and the urban environment 2The physics of star-forming clouds and the urban environment 3The physics of star-forming clouds and the urban environment 4The physics of star-forming clouds and the urban environment 5The physics of star-forming clouds and the urban environment 6Alexza Pharmaceuticals to Present AZ 004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting 1957 1Alexza Pharmaceuticals to Present AZ 004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting 1957 2Study in 7 000 men and women ties obesity inflammatory proteins to heart failure risk 18224 1Study in 7 000 men and women ties obesity inflammatory proteins to heart failure risk 18224 2Study in 7 000 men and women ties obesity inflammatory proteins to heart failure risk 18224 3Strategies for Winning Clinical Investigators in a Competitive Marketplace 18219 1Strategies for Winning Clinical Investigators in a Competitive Marketplace 18219 2High blood pressure still sneaking past doctors Stanford study shows 18215 1High blood pressure still sneaking past doctors Stanford study shows 18215 2High blood pressure still sneaking past doctors Stanford study shows 18215 3
...ls can be genetically modified to brandish a power...attack and kill leukemic cells. This finding, from...tal, suggests a way to improve the outcome of chil... leukemia (ALL) or other blood cancers. , Results ... online issue of Blood. , The researchers demonst...
... pump could come in the form of corncobs, cornstal...ing to a joint feasibility study for the departmen...eted Oak Ridge National Laboratory report outlines...f biomass ?any organic matter that is available on... percent of the nation,s petroleum consumption for...
...Buffalo have shown for the first time how histatin...va, kills the oral pathogen Candida albicans, the ...tions. , Researchers led by Mira Edgerton, D.D.S....fic membrane protein called TRK1p, which regulates...he pathogenic fungus Candida albicans and allows t...
...th roughly every 26 million years, leading some sc...e collisions with comets or asteroids. A researche...dinary predators are at fault instead. , Adam Lipo...merical model of many species competing for both f...rm that controls mutation rates, allowing new spec...
Other Biology News:Genetically Modified Natural Killer Immune Cells Attack, Kill Leukemia Cells 2Growth in biomass could put US on road to energy independence 2Discovery may lead to better Candidiasis drug 2
Control primers and template for 5kb and 15 kb products.
Our original highly-purified, robust Taq Polymerase which delivers consistently high yields and minimal background
Oligonucleotides from Thermo Scientific
Cag-A (IgG) -Ab EIA Sample Size: 10 l
Biology Products: